In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

Kenya is one of nine African countries selected for the initial rollout of lenacapavir (LEN), a new injectable drug for human ...

Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

HHS canceled federal funding for mRNA vaccine development. Experts said this could affect our preparedness for future ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of the diverse variants of HIV. Neutralizing antibodies are proteins ...

The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

China's National Center for AIDS/STD Control and Prevention, along with other research teams, has recently completed the ...

A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National ...